Skip to Main Content

Paper Details

Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy - naive adults with HIV-1 infection.
AIDS
49
2022
3TC, DTG, FTC, GEMINI, GEMINI-1, HIV, HIV-1, HIV-1 RNA, HIV-1 infection, M184V, Participants, R263R, TDF, dolutegravir, emtricitabine, lamivudine, nucleoside, nucleoside reverse transcriptase, participant, participants, tenofovir disoproxil fumarate
Author NameAffiliation
Jos?? R ArribasHospital Universitario La Paz
Amanda ClarkeRoyal Sussex County Hospital, and Brighton & Sussex Medical School
  • 1 - 2

Datasets

Release 1.2